Researchers have developed an artificial intelligence model that accurately predicts outcomes for cancer patients from tissue samples, marking a significant advancement in using AI for the likely course of the disease and personalized treatment strategies. The innovative approach, described in the journal Nature Communications, analyses the spatial arrangement of cells in tissue samples. Cell spatial organization is like a complex jigsaw puzzle where each cell serves as a unique piece, fitting together meticulously to form a cohesive tissue or organ structure, the researchers said.
"The study showcases the remarkable ability of AI to grasp these intricate spatial relationships among cells within tissues, extracting subtle information previously beyond human comprehension while predicting patient outcomes," said study leader Guanghua Xiao, a professor at the University of Texas Southwestern Medical Center in the US.
Tissue samples are routinely collected from patients and placed on slides for interpretation by pathologists, who analyze them to make diagnoses. However, this process is time-consuming, and interpretations can vary among pathologists, the researchers said. Various AI models built in the past several years can perform some aspects of a pathologist's job, for example, identifying cell types or using cell proximity as a proxy for interactions between cells.
Also Read: Rohit Bal health update: Fashion designer thanks friends for wishes, says he is recovering
However, these models don't successfully recapitulate more complex aspects of how pathologists interpret tissue images, such as discerning patterns in cell spatial organization and excluding extraneous "noise" in images that can muddle interpretations. The new AI model, named Ceograph, mimics how pathologists read tissue slides, starting with detecting cells in images and their positions. From there, it identifies cell types as well as their morphology and spatial distribution, creating a map in which the arrangement, distribution, and interactions of cells can be analyzed.
The researchers successfully applied this tool to three clinical scenarios using pathology slides. In one, they used Ceograph to distinguish between two subtypes of lung cancer, adenocarcinoma or squamous cell carcinoma. In another, they predicted the likelihood of potentially malignant oral disorders and precancerous lesions of the mouth progressing to cancer. In the third, the team identified which lung cancer patients were most likely to respond to a class of medications called epidermal growth factor receptor inhibitors.
